Evidence map›Paper›PMID 28435285›Full record

ArticleOncoTargets and therapy2017

Exploratory cohort study and meta-analysis of

Si Sun, Hui Yu, Huijie Wang, Xinmin Zhao, Xintai Zhao, Xianghua Wu, Jie Qiao, Jianhua Chang, Jialei Wang

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in OncoTargets and therapy, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Si SunDepartment of Medical Oncology, Fudan University Shanghai Cancer Center.
Hui YuDepartment of Medical Oncology, Fudan University Shanghai Cancer Center.
Huijie WangDepartment of Medical Oncology, Fudan University Shanghai Cancer Center.
Xinmin ZhaoDepartment of Medical Oncology, Fudan University Shanghai Cancer Center.
Xintai ZhaoShanghai Shines Biomedical Co. Ltd., Shanghai, People's Republic of China.
Xianghua WuDepartment of Medical Oncology, Fudan University Shanghai Cancer Center.
Jie QiaoDepartment of Medical Oncology, Fudan University Shanghai Cancer Center.
Jianhua ChangDepartment of Medical Oncology, Fudan University Shanghai Cancer Center.
Jialei WangDepartment of Medical Oncology, Fudan University Shanghai Cancer Center.
Shanghai Medical College of Fudan University · CNFudan University Shanghai Cancer Center · CNShine Micro (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNon-small-cell lung cancer (NSCLC) patients with epidermal growth factor receptor ( PATIENTS AND

methodsA cohort of advanced NSCLC patients with

resultsThe exploratory cohort study included 140 patients. Patients with and without the

conclusionThe expanded meta-analysis results demonstrated the positive

Indexed as

BIMclinical outcomeEGFRNSCLC

Identifiers

PMID28435285
PMCPMC5388210
OpenAlexW2604762780

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.